Neuroleptic Malignant Syndrome Associated with Metoclopramide Use in a Boy: Case Report and Review of the Literature

American Journal of Therapeutics

Volumn 23, Issue 5, 2016, Pages e1246-e1249

  Wittmann, Osnat ^a   Sadot, Efraim ^a   Bisker Kassif, Orly ^a   Scolnik, Dennis ^b   Tavor, Oren ^a   Glatstein, Miguel M ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

hyperpyrexia; metoclopramide; neuroleptic malignant syndrome

Indexed keywords

CEFTRIAXONE; CLINDAMYCIN; DOPAMINE; FRESH FROZEN PLASMA; METOCLOPRAMIDE; PROTHROMBIN; SODIUM CHLORIDE; VANCOMYCIN; ANTIEMETIC AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT;

ACUTE GASTROENTERITIS; ADOLESCENT; ALPHA HEMOLYTIC STREPTOCOCCUS; ANION GAP; ASSISTED VENTILATION; BLOOD CULTURE; CASE REPORT; CONSCIOUSNESS DISORDER; ECHOCARDIOGRAPHY; FOLLOW UP; GLASGOW COMA SCALE; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPERPYREXIA; HYPERTHERMIA; HYPOTENSION; INDUCED HYPOTHERMIA; INTERNATIONAL NORMALIZED RATIO; INTUBATION; MALE; METABOLIC ACIDOSIS; MUSCLE RIGIDITY; NEUROLEPTIC MALIGNANT SYNDROME; PALLOR; PARTIAL THROMBOPLASTIN TIME; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; SHIVERING; THROMBOCYTOPENIA; VOMITING;

ADOLESCENT; ANTIEMETICS; DOPAMINE D2 RECEPTOR ANTAGONISTS; FOLLOW-UP STUDIES; HUMANS; MALE; METOCLOPRAMIDE; NEUROLEPTIC MALIGNANT SYNDROME;

EID: 84988421895     PISSN: 10752765     EISSN: 15363686     Source Type: Journal    
DOI: 10.1097/MJT.0000000000000320     Document Type: Review

References (20)

1. Croarkin PE, Emslie GJ, Mayes TL. Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: A review of published cases. J Clin Psychiatry. 2008;69:1157-1165.
2. Grigg JR. Neuroleptic malignant syndrome and malignant hyperthermia. Am J Psychiatry. 1988;145:1175.
3. Delay J, Pichot P, Lemperiere T, et al. A non-phenothiazine and non-reserpine major neuroleptic, haloperidol, in the treatment of psychoses. Ann Med Psychol (Paris). 1960;118: 145-152.
4. Bhanushali MJ, Tuite PJ. The evaluation and management of patients with neuroleptic malignant syndrome. Neurol Clin. 2004;22:389-411.
5. Margeti-c B, Aukst-Margeti-c B. Neuroleptic malignant syndrome and its controversies. Pharmacoepidemiol Drug Saf. 2010;19:429-435.
6. Fujita Y, Yasukawa T, Mihira M, et al. Metoclopramide in a patient with renal failure may be an increased risk of neuroleptic malignant syndrome. Intensive Care Med. 1996;22:717.
7. Friedman LS, Weinrauch LA, D'Elia JA. Metoclopramide-induced neuroleptic malignant syndrome. Arch Intern Med. 1987;147:1495-1497.
8. Stein MH, Sorscher M, Caroff SN. Neuroleptic malignant syndrome induced by metoclopramide in an infant with Freeman-Sheldon syndrome. Anesth Analg. 2006;103: 786-787.
9. Addonizio G, Susman VL, Roth SD. Neuroleptic malignant syndrome: review and analysis of 115 cases. Biol Psychiatry. 1987;22:1004-1020.
10. Nonino F, Campomori A. Neuroleptic malignant syndrome associated with metoclopramide. Ann Pharmacother. 1999;33:644-645.
11. Heinemann F, Assion HJ, Laux G. Neuroleptic malignant syndrome from treatment with antidepressives. Fortschr Neurol Psychiatr. 1997;65:208-213.
12. Gurrera RJ. Diaphoresis and dehydration during neuroleptic malignant syndrome: Preliminary findings. Psychiatry Res. 1996;64:137-145.
13. Gurrera RJ, Romero JA. Sympathoadrenomedullary activity in the neuroleptic malignant syndrome. Biol Psychiatry. 1992;32:334-343.
14. Velamoor VR, Norman RM, Caroff SN, et al. Progression of symptoms in neuroleptic malignant syndrome. J Nerv Ment Dis. 1994;182:168-173.
15. Nisijima K, Shioda K. A rare case of neuroleptic malignant syndrome without elevated serum creatine kinase. Neuropsychiatr Dis Treat. 2014;10:403-407.
16. Becker JA, Stewart LK. Heat-related illness. Am Fam Physician. 2011;83:1325-1330.
17. Bienvenu OJ, Neufeld KJ, Needham DM. Treatment of four psychiatric emergencies in the intensive care unit. Crit Care Med. 2012;40:2662-2670.
18. Dykstra TJ, Menolasino MJ. Neuroleptic malignant syndrome: Case report and review. J Am Osteopath Assoc. 1997;97:355-357.
19. Perry PJ, Wilborn CA. Serotonin syndrome vs neuroleptic malignant syndrome: A contrast of causes, diagnoses, and management. Ann Clin Psychiatry. 2012;24: 155-162.
20. Hashim H, Zeb-un-Nisa, Alrukn SA, et al. Drug resistant neuroleptic malignant syndrome and the role of electroconvulsive therapy. J Pak Med Assoc. 2014;64:471-473.